Literature DB >> 2987337

Autonomic dysfunction and Eaton Lambert syndrome.

M B Mamdani, R L Walsh, F A Rubino, R T Brannegan, M H Hwang.   

Abstract

Autonomic dysfunction associated with Eaton Lambert syndrome in a patient with oat cell carcinoma of the lung is reported. Widespread postganglionic adrenergic and cholinergic defects suggested the presence of autonomic neuropathy. Clinical remission accompanied tumor regression after combined chemotherapy and radiation.

Entities:  

Mesh：

Year:  1985        PMID： 2987337     DOI： 10.1016/0165-1838(85)90046-3

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN： 0165-1838


  6 in total

1.  Abnormalities of autonomic function in the Lambert Eaton myasthenic syndrome.

Authors:  J P Heath; D J Ewing; R E Cull
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-03       Impact factor: 10.154

Review 2.  Postganglionic cholinergic dysautonomia with incomplete recovery: a clinical, neurophysiological and immunological case study.

Authors:  R Baron; F Engler
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

3.  Acute autonomic and sensory neuropathy: report of an autopsy case.

Authors:  H Tohgi; M Sano; K Sasaki; H Suzuki; T Sato; T Iwasaki; R Satodate
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Lambert Eaton syndrome: autonomic neuropathy and inappropriate antidiuretic hormone secretion in a patient with small cell carcinoma of the lung.

Authors:  H Manji; M S Schwartz; R O McKeran
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

5.  Lambert-Eaton syndrome antibodies inhibit acetylcholine release and P/Q-type Ca2+ channels in electric ray nerve endings.

Authors:  Y Satoh; N Hirashima; H Tokumaru; M P Takahashi; J Kang; M P Viglione; Y I Kim; Y Kirino
Journal:  J Physiol       Date:  1998-04-15       Impact factor: 5.182

Review 6.  Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.

Authors:  Michael T Flink; William D Atchison
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.